BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2650652)

  • 1. Evaluation of the Keystone Diagnostic Quik Test. A paper chromatography test for drugs of abuse in urine.
    Schwartz RH; Bogema S; Thorne MM
    Arch Pathol Lab Med; 1989 Apr; 113(4):363-4. PubMed ID: 2650652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Keystone Diagnostics Quik Test using previously screened urine specimens.
    Bogema S; Schwartz R; Godwin I
    J Anal Toxicol; 1988; 12(5):272-3. PubMed ID: 3226124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity testing of commercial urine cocaine metabolite assays: II. Sensitivity, specificity, accuracy, and confirmation by gas chromatography/mass spectrometry.
    Cone EJ; Mitchell J
    J Forensic Sci; 1989 Jan; 34(1):32-45. PubMed ID: 2918287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of clinical toxicology urine specimens using the KDI Quik test.
    Kaplan RM; Fochtman F; Brunett P; White C; Heller MB
    J Toxicol Clin Toxicol; 1989; 27(6):369-73. PubMed ID: 2697762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ; Walsh JM; Leaverton PE
    J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of validity of the KDI Quik Test Drug Screen for detection of benzoylecgonine in urine.
    Cone EJ; Menchen SL
    J Anal Toxicol; 1987; 11(6):276-7. PubMed ID: 3431098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for marijuana and cocaine abuse by immunoanalysis and gas chromatography.
    Garcia-Jimenez S; Heredia-Lezama K; Bilbao-Marcos F; Fuentes-Lara G; Monroy-Noyola A; Deciga-Campos M
    Ann N Y Acad Sci; 2008 Oct; 1139():422-5. PubMed ID: 18991889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discussion of the KDI Quik Test Drug Screen.
    Wells H
    J Anal Toxicol; 1988; 12(2):111. PubMed ID: 3379920
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of an on-site test for its use in post-mortem blood.
    Arroyo A; Sánchez M; Palahí M; Barbal M; Marrón MA; Mora A
    Leg Med (Tokyo); 2011 Sep; 13(5):240-4. PubMed ID: 21821456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary comparative study on the usefulness of instant-view'TM M-1 and Triage DOA in testing for drugs-of-abuse in forensic urine samples].
    Moriya F
    Chudoku Kenkyu; 2012 Sep; 25(3):243-6. PubMed ID: 23057404
    [No Abstract]   [Full Text] [Related]  

  • 15. Validity testing of commercial urine cocaine metabolite assays: III. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for detection of cocaine and cocaine metabolite.
    Cone EJ
    J Forensic Sci; 1989 Jul; 34(4):991-5. PubMed ID: 2760594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans.
    Cone EJ; Menchen SL; Paul BD; Mell LD; Mitchell J
    J Forensic Sci; 1989 Jan; 34(1):15-31. PubMed ID: 2918277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
    Lachenmeier K; Musshoff F; Madea B
    Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.